Schedule 13D ownership disclosure

AGEX THERAPEUTICS INC

Security class unavailable · CUSIP: 00848H108

Event date: 2020-11-11

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
50.0000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001104659-20-127418
Form type
SC 13D/A
Filer
Serina Therapeutics, Inc.
CIK
CIK 1708599
Filed
Nov 19, 2020
Reporting period
Nov 11, 2020
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub